CA2537349A1 - Nouveau 4-piperidine-carboxamide et leur utilisation pour preparer des medicaments contre des troubles lies au recepteur de la 5-ht2a - Google Patents
Nouveau 4-piperidine-carboxamide et leur utilisation pour preparer des medicaments contre des troubles lies au recepteur de la 5-ht2a Download PDFInfo
- Publication number
- CA2537349A1 CA2537349A1 CA002537349A CA2537349A CA2537349A1 CA 2537349 A1 CA2537349 A1 CA 2537349A1 CA 002537349 A CA002537349 A CA 002537349A CA 2537349 A CA2537349 A CA 2537349A CA 2537349 A1 CA2537349 A1 CA 2537349A1
- Authority
- CA
- Canada
- Prior art keywords
- independently substituted
- alkyl
- alkoxy
- optionally independently
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302369-4 | 2003-09-03 | ||
SE0302369A SE0302369D0 (sv) | 2003-09-03 | 2003-09-03 | New compounds |
US50529503P | 2003-09-23 | 2003-09-23 | |
US60/505,295 | 2003-09-23 | ||
PCT/SE2004/001236 WO2005021505A1 (fr) | 2003-09-03 | 2004-08-27 | Nouveau 4-piperidine-carboxamide et leur utilisation pour preparer des medicaments contre des troubles lies au recepteur de la 5-ht2a |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2537349A1 true CA2537349A1 (fr) | 2005-03-10 |
Family
ID=34277853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002537349A Abandoned CA2537349A1 (fr) | 2003-09-03 | 2004-08-27 | Nouveau 4-piperidine-carboxamide et leur utilisation pour preparer des medicaments contre des troubles lies au recepteur de la 5-ht2a |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1663972A1 (fr) |
JP (1) | JP2007504221A (fr) |
AU (1) | AU2004268919A1 (fr) |
CA (1) | CA2537349A1 (fr) |
WO (1) | WO2005021505A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070083484A (ko) | 2004-07-14 | 2007-08-24 | 피티씨 테라퓨틱스, 인크. | C형 간염 치료 방법 |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB932487A (en) * | 1960-07-25 | 1963-07-31 | D G Searle & Co | Piperidine derivatives |
US5269096A (en) * | 1993-01-15 | 1993-12-14 | Rene Hade | Removable lightweight window guard |
AU680004B2 (en) * | 1993-05-26 | 1997-07-17 | Syntex (U.S.A.) Inc. | Novel 1-phenylalkanone 5-HT4 receptor ligands |
US6150393A (en) * | 1998-12-18 | 2000-11-21 | Arena Pharmaceuticals, Inc. | Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
-
2004
- 2004-08-27 EP EP04775342A patent/EP1663972A1/fr not_active Withdrawn
- 2004-08-27 WO PCT/SE2004/001236 patent/WO2005021505A1/fr active Application Filing
- 2004-08-27 AU AU2004268919A patent/AU2004268919A1/en not_active Abandoned
- 2004-08-27 CA CA002537349A patent/CA2537349A1/fr not_active Abandoned
- 2004-08-27 JP JP2006525301A patent/JP2007504221A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2004268919A1 (en) | 2005-03-10 |
EP1663972A1 (fr) | 2006-06-07 |
JP2007504221A (ja) | 2007-03-01 |
WO2005021505A1 (fr) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10927080B2 (en) | Pyridinone dicarboxamide for use as bromodomain inhibitors | |
US20060148818A1 (en) | Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders | |
US9776961B2 (en) | Crystal of pyrrole derivative and method for producing the same | |
WO2005085252A1 (fr) | Composes de 1,2-a' pyrazine imidazo interagissant avec les proteines kinases | |
TW200403224A (en) | Novel compounds | |
WO2003028728A1 (fr) | 4-(piperazinyl-1yle substitue en 4)-butylcarboxamides utilises en tant que ligands selectifs du sous-type de la dopamine d3 | |
WO2005080390A1 (fr) | Derives d'imidazopyridine antagonistes de bsr-3 | |
EP3359531A1 (fr) | Composés 2-oxo-1,2-dihydropyridine-3,5-dicarboxamide utilisés en tant qu'inhibiteurs de bromodomaines | |
TW200831074A (en) | Diaryl ether derivatives and uses thereof | |
US20050215555A1 (en) | Inhibitors of 5-HT2A receptor | |
RU2162470C2 (ru) | 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения | |
CN116057042A (zh) | 丙烯酰胺取代的茚满化合物及其治疗用途 | |
AU2004277346B2 (en) | Bicyclo[3.1.1]heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
US20050215589A1 (en) | Inhibitors of 5-HT2A receptor | |
CA2537349A1 (fr) | Nouveau 4-piperidine-carboxamide et leur utilisation pour preparer des medicaments contre des troubles lies au recepteur de la 5-ht2a | |
EP0585116B1 (fr) | Dérivés de 1-alkoxy-naphtalène-2-carboxamide avec grande affinité pour le récepteur de sérotonine 5-HT1A | |
JPH08277267A (ja) | 抗うつ作用を有するナフチル−モナジンのヘテロアリールアミノアルキル誘導体 | |
WO2018158210A1 (fr) | Dérivés de pyridyle utilisés en tant qu'inhibiteurs de bromodomaine | |
CN116082259B (zh) | 氨基甲酸酯基或氨甲酰基取代的5-ht2b拮抗剂 | |
JP2002538154A (ja) | セロトニン作動活性を有するn−置換イミド誘導体 | |
ZA200602756B (en) | Novel tetraydrospiro{piperidine-2,7'-pyrrolo[3,2-b]pyridine derivatives and novel indole derivatives useful in the treatment of 5-HT6 receptor-related disorders | |
KR20060134927A (ko) | 사람 orl1 수용체에 대한 효능제로서의바이사이클로[3.1.1]헵탄 치환된 벤즈이미다졸론 및퀴나졸리논 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |